Skip to content

Drug interactions

Oxybutynin transdermal + Rimantadine

Severity: Minor

Oxybutynin transdermal and Rimantadine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Transdermal oxybutynin has lower systemic antimuscarinic exposure than oral oxybutynin, but it can still cause anticholinergic effects. Combined with rimantadine, additive CNS effects such as confusion or dizziness are possible, particularly in older patients, though data are limited.

What this interaction means in plain words

Oxybutynin transdermal and Rimantadine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible additive anticholinergic and CNS effects.

What to do

Monitor for confusion, dizziness and urinary retention in older patients. Consider stopping one agent if cognitive effects develop.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Oxybutynin transdermal and Rimantadine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Oxybutynin transdermal with Rimantadine?

MediHelp rates the interaction as minor. Oxybutynin transdermal and Rimantadine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Transdermal oxybutynin has lower systemic antimuscarinic exposure than oral oxybutynin, but it can still cause anticholinergic effects. Combined with rimantadine, additive CNS effects such as confusion or dizziness are possible, particularly in older patients, though data are limited.

How serious is the interaction between Oxybutynin transdermal and Rimantadine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for confusion, dizziness and urinary retention in older patients. Consider stopping one agent if cognitive effects develop.

What other medicines interact with Rimantadine?

MediHelp also lists interactions of Rimantadine with, for example, Henbane, Atropine iv /, Glycopyrrolate. The full list is on the Rimantadine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in